Cellulite,edema
Conditions
Interventions
Experimental group: 20 women who have cellulite in the buttocks and hamstring region will receive subcutaneous injections of ozone at a concentration of 10 micrograms/ml with injected volume at each p
D063926
Sponsors
Una Uberlândia
Una Uberlândia
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: The sample will be composed of patients of both genders aged between 18 and 70 years who present gynoid lipodystrophy and who consent to sign and date the consent form and are available to follow the protocol
Exclusion criteria
Exclusion criteria: Patients who do not consent to sign the consent form and/or show unwillingness to follow the research procedures, patients with a history of bleeding, pregnancy, hyperthyroidism, even compensated cardiac arrhythmia, severe cardiac instability, glucose-6-phosphate dehydrogenase deficiency will be excluded (favism), allergic and/or intolerant to ozone., thrombocytopenia, hemochromatosis, patients being treated with iron or copper
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is a reduction in cellulite by at least 50% compared to placebo, which will be determined by evaluating the photographic and thermographic record before and after the intervention. To assess the improvement or reduction of cellulite, the Fibro Edema Geloid Severity Scale will be used and photographic and thermographic records of the treated area will be performed. This evaluation will be done at the beginning and at the end of the treatment. The images will be evaluated by two independent operators, without one having access to the other's evaluation. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome is improved patient satisfaction, which will be determined through validated questionnaires. Participants will answer the adapted questionnaires: Patient Satisfaction Analysis, Segot-chicq et al. (2007) and the Global Aesthetic Improvement Scale (GAIS), Narins (2003), which is used to classify the response to treatments, allowing a comparative assessment at different times after the therapeutic intervention. | — |
Countries
Brazil
Contacts
Public ContactSilene Ribeiro
Outcome results
None listed